Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2024 Jan 15:rs.3.rs-3846125.
doi: 10.21203/rs.3.rs-3846125/v1.

Relationship between Neuroimaging and Cognition in Frontotemporal Dementia: A [18 F]FDG PET and Structural MRI Study

Affiliations

Relationship between Neuroimaging and Cognition in Frontotemporal Dementia: A [18 F]FDG PET and Structural MRI Study

Salih Cayir et al. Res Sq. .

Update in

Abstract

Background: Frontotemporal dementia (FTD) is a clinically and pathologically heterogeneous condition with a prevalence comparable to Alzheimer's Disease for patients under sixty-five years of age. Gray matter (GM) atrophy and glucose hypometabolism are important biomarkers for the diagnosis and evaluation of disease progression in FTD. However, limited studies have systematically examined the association between cognition and neuroimaging in FTD using different imaging modalities in the same patient group.

Methods: We examined the association of cognition using Montreal Cognitive Assessment (MoCA) with both GM volume and glucose metabolism using structural magnetic resonance imaging (MRI) and 18F-fluorodeoxyglucose positron emission tomography scanning ([18F]FDG PET) in 21 patients diagnosed with FTD. Standardized uptake value ratio (SUVR) using the brainstem as a reference region was the primary outcome measure for [18F]FDG PET. Partial volume correction was applied to PET data to account for disease-related atrophy.

Results: Significant positive associations were found between whole-cortex GM volume and MoCA scores (r = 0.461, p = 0.035). The association between whole-cortex [18F]FDG SUVR and MoCA scores was not Significant (r = 0.374, p = 0.094). GM volumes of the frontal cortex (r = 0.540, p = 0.011), caudate (r = 0.616, p = 0.002), and insula (r = 0.568, p = 0.007) were also Significantly correlated with MoCA, as were SUVR values of the insula (r = 0.508, p = 0.018), thalamus (r = 0.478, p = 0.028), and posterior cingulate cortex (PCC) (r = 0.472, p = 0.030).

Discussion: Whole-cortex atrophy is associated with cognitive dysfunction, and this effect is larger than for cortical hypometabolism as measured with [18F]FDG PET. At the regional level, focal atrophy and/or hypometabolism in the frontal lobe, insula, PCC, thalamus, and caudate seem to imply the importance of these regions for the decline of cognitive function in FTD. Furthermore, these results highlight how functional and structural changes may not overlap and might contribute to cognitive dysfunction in FTD in different ways. Our findings provide insight into the relationships between structural, metabolic, and cognitive changes due to FTD.

PubMed Disclaimer

Conflict of interest statement

Additional Declarations: No competing interests reported. Conflict of interest: All authors declare that they have no conflicts of interests.

Figures

Figure 1
Figure 1
Scatterplots of the associations of Montreal Cognitive Assessment (MoCA) scores with cortical GM volume (A, C, E) and [18F]FDG SUVR (B, D, F); *: Pearson’s correlation results are significant (*) at alpha = 0.05 level (uncorrected).
Figure 2
Figure 2
Visual representation of the associations (Pearson’s r) between region-wise GM volume and MoCA scores (A), region-wise [18F]FDG SUVR and MoCA scores (B), region-wise GM volume and [18F]FDG SUVR (C). The same value for left and right GM volume and SUVR is shown for each Freesurfer ROI. Significance of correlations is not highlighted.
Figure 3
Figure 3
Scatterplots of the associations of total tau (t-tau) levels with whole-cortex GM volume (A) and whole-cortex [18F]FDG SUVR (B). Pearson’s correlation results are significant (*) at alpha = 0.05 level (uncorrected).

References

    1. Ang L. C., Yap P., Tay S. Y., Koay W. I., & Liew T. M. (2023). Examining the Validity and Utility of Montreal Cognitive Assessment Domain Scores for Early Neurocognitive Disorders. J Am Med Dir Assoc, 24(3), 314–320.e312. 10.1016/j.jamda.2022.12.028 - DOI - PMC - PubMed
    1. Bejanin A., Tammewar G., Marx G., Cobigo Y., Iaccarino L., Kornak J., Staffaroni A. M., Dickerson B. C., Boeve B. F., Knopman D. S., Gorno-Tempini M., Miller B. L., Jagust W. J., Boxer A. L., Rosen H. J., & Rabinovici G. D. (2020). Longitudinal structural and metabolic changes in frontotemporal dementia. Neurology, 95(2), e140–e154. 10.1212/wnl.0000000000009760 - DOI - PMC - PubMed
    1. Beyer L., Meyer-Wilmes J., Schönecker S., Schnabel J., Sauerbeck J., Scheifele M., Prix C., Unterrainer M., Catak C., Pogarell O., Palleis C., Perneczky R., Danek A., Buerger K., Bartenstein P., Levin J., Rominger A., Ewers M., & Brendel M. (2021). Cognitive reserve hypothesis in frontotemporal dementia: A FDG-PET study. Neuroimage Clin, 29, 102535. 10.1016/j.nicl.2020.102535 - DOI - PMC - PubMed
    1. Bocchetta M., Gordon E., Cardoso M. J., Modat M., Ourselin S., Warren J. D., & Rohrer J. D. (2018). Thalamic atrophy in frontotemporal dementia - Not just a C9orf72 problem. Neuroimage Clin, 18, 675–681. 10.1016/j.nicl.2018.02.0195. - DOI - PMC - PubMed
    1. Bott N. T., Radke A., Stephens M. L., & Kramer J. H. (2014). Frontotemporal dementia: diagnosis, deficits and management. Neurodegener Dis Manag, 4(6), 439–454. 10.2217/nmt.14.34 - DOI - PMC - PubMed

Publication types

LinkOut - more resources